on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has disclosed its current positions and dealings in Spire Healthcare Group plc's securities pursuant to Rule 8.3 of the Takeover Code. As of September 30, 2025, Vanguard held a 3.58% interest in Spire Healthcare's 1p ordinary shares, totaling 14,407,467 shares. This disclosure indicates a significant investment stake by Vanguard in Spire Healthcare.
The announcement also confirms that Vanguard sold 47,117 of Spire's ordinary shares at a price of 2.49 GBP each. No additional transactions involving cash-settled or stock-settled derivatives have been reported. Furthermore, the disclosure reveals no agreements or arrangements relating to securities, options, or derivatives.
This report provides key insights into Vanguard's strategic investments in the healthcare sector, showcasing its role as a substantial shareholder in Spire Healthcare.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news